Appili Therapeutics Inc.
APLIF
$0.01
$0.0026.39%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 356.04% | -77.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 356.04% | -77.94% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 356.04% | -77.94% | |||
| SG&A Expenses | 1.19% | 287.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -41.81% | 250.99% | |||
| Operating Income | 45.30% | -303.73% | |||
| Income Before Tax | -64.38% | -7.55% | |||
| Income Tax Expenses | -83.05% | 321.43% | |||
| Earnings from Continuing Operations | -58.62% | -10.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -58.62% | -10.76% | |||
| EBIT | 45.30% | -303.73% | |||
| EBITDA | 45.32% | -304.82% | |||
| EPS Basic | -30.43% | -30.19% | |||
| Normalized Basic EPS | -36.59% | -24.24% | |||
| EPS Diluted | -30.43% | -30.19% | |||
| Normalized Diluted EPS | -36.59% | -24.24% | |||
| Average Basic Shares Outstanding | 20.58% | -14.48% | |||
| Average Diluted Shares Outstanding | 20.58% | -14.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||